GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytokinetics Inc (NAS:CYTK) » Definitions » E10

Cytokinetics (Cytokinetics) E10 : $-2.50 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cytokinetics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cytokinetics's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.50 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -8.80% per year. During the past 5 years, the average E10 Growth Rate was -4.40% per year. During the past 10 years, the average E10 Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cytokinetics was 42.20% per year. The lowest was -8.80% per year. And the median was 5.80% per year.

As of today (2024-04-27), Cytokinetics's current stock price is $65.34. Cytokinetics's E10 for the quarter that ended in Dec. 2023 was $-2.50. Cytokinetics's Shiller PE Ratio of today is .


Cytokinetics E10 Historical Data

The historical data trend for Cytokinetics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytokinetics E10 Chart

Cytokinetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.26 -1.94 -1.82 -2.06 -2.50

Cytokinetics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.06 -2.16 -2.24 -2.34 -2.50

Competitive Comparison of Cytokinetics's E10

For the Biotechnology subindustry, Cytokinetics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytokinetics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytokinetics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cytokinetics's Shiller PE Ratio falls into.



Cytokinetics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cytokinetics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.38/129.4194*129.4194
=-1.380

Current CPI (Dec. 2023) = 129.4194.

Cytokinetics Quarterly Data

per share eps CPI Adj_EPS
201403 -0.270 99.695 -0.351
201406 -0.230 100.560 -0.296
201409 -0.160 100.428 -0.206
201412 0.230 99.070 0.300
201503 -0.230 99.621 -0.299
201506 -0.270 100.684 -0.347
201509 -0.230 100.392 -0.297
201512 -0.240 99.792 -0.311
201603 -0.310 100.470 -0.399
201606 -0.290 101.688 -0.369
201609 0.770 101.861 0.978
201612 0.160 101.863 0.203
201703 -0.620 102.862 -0.780
201706 -0.600 103.349 -0.751
201709 -0.600 104.136 -0.746
201712 -0.750 104.011 -0.933
201803 -0.560 105.290 -0.688
201806 -0.510 106.317 -0.621
201809 -0.400 106.507 -0.486
201812 -0.480 105.998 -0.586
201903 -0.540 107.251 -0.652
201906 -0.560 108.070 -0.671
201909 -0.500 108.329 -0.597
201912 -0.510 108.420 -0.609
202003 -0.660 108.902 -0.784
202006 -0.680 108.767 -0.809
202009 -0.050 109.815 -0.059
202012 -0.620 109.897 -0.730
202103 -0.660 111.754 -0.764
202106 -0.860 114.631 -0.971
202109 -0.950 115.734 -1.062
202112 -0.360 117.630 -0.396
202203 -1.050 121.301 -1.120
202206 -0.230 125.017 -0.238
202209 -1.520 125.227 -1.571
202212 -1.450 125.222 -1.499
202303 -1.380 127.348 -1.402
202306 -1.340 128.729 -1.347
202309 -1.350 129.860 -1.345
202312 -1.380 129.419 -1.380

Add all the adjusted EPS together and divide 10 will get our e10.


Cytokinetics  (NAS:CYTK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cytokinetics E10 Related Terms

Thank you for viewing the detailed overview of Cytokinetics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytokinetics (Cytokinetics) Business Description

Traded in Other Exchanges
Address
350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Executives
Robert I Blum officer: EVP, Corp. Development & CBO 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
John T Henderson director 320 WAKARA WAY, SALT LAKE CITY UT 84108
Fady Ibraham Malik officer: SVP Research & Early Dev 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Wendall Wierenga director 12790 EL CAMINO REAL, C/O NEUROCRINE BIOSCIENCES, SAN DIEGO CA 92130
Muna Bhanji director C/O CYTOKINETICS, INCORPORATED, 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Robert Wong officer: VP, Chief Accounting Officer 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Ching Jaw officer: SVP Finance & CFO 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Sandford D Smith director C/O ARIAD PHARMACEUTICALS INC, 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
B Lynne Parshall director 2855 GAZELLE COURT, CARLSBAD CA 92010
Santo J Costa director
Kaye Edward M. Md director 3450 MONTE VILLA PARKWAY, BOTHELL WA 98011
Robert Arthur Harrington director C/O CYTOKINETICS, INCORPORATED, 350 OYSTER POINT BLVD., SOUTH SAN FRANCISCO CA 94080
Mark A Schlossberg officer: SVP - Legal & General Counsel C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
David Cragg officer: V.P., Human Resources 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
L Patrick Gage director C/O NEOSE TECHNOLOGIES, 102 WITMER RD, HORSHAM PA 19044